buntanetap/posiphen
Sponsors
Annovis Bio Inc.
Conditions
Alzheimer DiseaseAlzheimer's Dementia (AD)Deep Brain StimulationEarly Alzheimers DiseaseParkinson's Disease (PD)Parkinson's Disease, Idiopathic
Phase 2
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
CompletedNCT05686044
Start: 2023-04-01End: 2024-02-13Updated: 2025-04-29
A Study of Buntanetap in Participants With PD
RecruitingNCT07284784
Start: 2026-01-09End: 2029-11-01Target: 500Updated: 2026-07-21
An Open-label Long-term Safety Study of Buntanetap in Participants With AD
Not yet recruitingNCT07757204
Start: 2026-09-21End: 2030-05-01Target: 400Updated: 2026-08-19
Phase 3
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
CompletedNCT05357989
Start: 2022-08-03End: 2023-12-04Updated: 2025-03-03
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
Active, not recruitingNCT06709014
Start: 2025-02-04End: 2028-06-01Target: 760Updated: 2026-05-18